The federal government has unveiled a significant $20 million investment in research and development projects focused on genomics, with three initiatives based at the University of Calgary receiving support. This announcement was made on Wednesday, March 18, 2026, by Karim Bardeesy, Parliamentary Secretary to Canada's Minister of Industry, Mélanie Joly, during an event at the University of Calgary.
Funding Details and Economic Strategy
The investment, administered through Genome Canada, targets 33 research and development projects nationwide. These projects aim to bridge the gap between academic research and industrial applications, leveraging the diverse potential of genomics—the study of genetic material. Bardeesy emphasized that this funding is a crucial component of a broader strategy to fortify Canada's economy in the face of increasing global challenges.
"Investing in research and development is part of a larger strategy to strengthen Canada's economy amid growing global pressures," Bardeesy stated. He highlighted that the investment is expected to catalyze an additional $45 million in private sector funding, amplifying its impact on innovation and commercialization.
Applications Across Multiple Sectors
The funded projects span a wide array of fields, demonstrating the versatility of genomics technology. Key areas include:
- Health: AI-powered precision cancer care and other medical advancements.
- Agriculture: Development of drought-resilient crops to enhance food security.
- Environment: Utilization of microbes to clean contaminated areas and improve sustainability.
- Advanced Manufacturing: Innovations in energy production, both conventional and clean energy.
Bardeesy described genomics as a "general-purpose technology" that, when paired with industry partnerships, can yield substantial benefits for Canadians. "It can have huge benefits to Canadians, improving health care, improving food security, making energy perform better," he explained. He projected that the genomics economy could generate trillions of dollars in value over the coming decades.
Canada's Competitive Edge and Challenges
Bardeesy pointed out that Canada holds a competitive advantage in biotechnology, with 1.5 times more active biotech patents than the global average. However, he stressed the need for improved commercialization efforts to fully capitalize on this technological prowess. "We need to do a better job of commercializing that technology," he noted, underscoring the importance of translating research into market-ready solutions.
University of Calgary's Role
The University of Calgary is positioned as a central hub in this genomics initiative. Corey Hogan, MP for Calgary Confederation and Parliamentary Secretary to the Minister of Energy and Natural Resources, praised the institution as "one of Canada's real gems" in research. He highlighted that UCalgary is the fifth-largest research institution in the country by funding, calling it "a key driver of Canadian research, of innovation, of productivity."
Dr. Rob Annan, President and CEO of Genome Canada, echoed this sentiment, affirming that UCalgary is not only a leader in Canadian science but particularly excels in genomics. Bardeesy added that genomics is "reshaping industries," with Calgary at the forefront of this transformation.
Broader Implications and Future Outlook
This investment reflects a strategic move to harness genomics for economic growth, addressing sectors critical to national well-being. By fostering collaborations between academia and industry, the government aims to accelerate innovation, enhance Canada's global competitiveness, and create sustainable economic opportunities. The focus on genomics underscores its potential to drive advancements in health, agriculture, and environmental sustainability, aligning with broader goals of economic resilience and technological leadership.
